Clinical review: Status epilepticus

Sarice Bassin, Teresa L. Smith*, Thomas P Bleck

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

58 Scopus citations


Status epilepticus (SE) has an annual incidence exceeding 100,000 cases in the United States alone, of which more than 20% result in death. Thus, increased awareness of presentation, etiologies, and treatment of SE is essential in the practice of critical care medicine. This review discusses current definitions of SE, as well as its clinical presentation and classification. The recent literature on epidemiology is reviewed, including morbidity and mortality data. An overview of the systemic pathophysiologic effects of SE is presented. Finally, significant studies on the treatment of acute SE and refractory SE are reviewed, including the use of anticonvulsants, such as benzodiazepines, and other drugs.

Original languageEnglish (US)
Pages (from-to)137-142
Number of pages6
JournalCritical Care
Issue number2
StatePublished - 2002


  • Anticonvulsants
  • Benzodiazepine
  • Epidemiology
  • Review
  • Status epilepticus

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Clinical review: Status epilepticus'. Together they form a unique fingerprint.

Cite this